BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IACS - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.iacs.es
X-WR-CALDESC:Eventos para IACS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20230413T080000
DTEND;TZID=Europe/Madrid:20230913T170000
DTSTAMP:20260426T082037
CREATED:20230413T113648Z
LAST-MODIFIED:20230413T113648Z
UID:10001759-1681372800-1694624400@www.iacs.es
SUMMARY:MSCA Postdoctoral Fellowships 2023 (HORIZON-MSCA-2023-PF-01)
DESCRIPTION:Type of action\nHORIZON-TMA-MSCA-PF-EF HORIZON TMA MSCA Postdoctoral Fellowships – European Fellowships\n\n\n\n\n\n\n\nType of MGA\n\nHORIZON Unit Grant [HORIZON-AG-UN]\n\n\n\n\n\n\n\n\n\nOpen for submission\n\n\n\n\n\n\n\n\nHORIZON-TMA-MSCA-PF-GF HORIZON TMA MSCA Postdoctoral Fellowships – Global Fellowships\n\n\n\n\n\n\n\n\nHORIZON Unit Grant [HORIZON-AG-UN]\n\n\n\n\nProject results are expected to contribute to the following outcomes: \nFor supported postdoctoral fellows \n\nIncreased set of research and transferable skills and competences\, leading to improved employability and career prospects of MSCA postdoctoral fellows within academia and beyond;\nNew mind-sets and approaches to R&I work forged through international\, inter-sectoral and interdisciplinary experience;\nEnhanced networking and communication capacities with scientific peers\, as well as with the general public that will increase and broaden the research and innovation impact.\n\nFor participating organisations \n\nIncreased alignment of working conditions for researchers in accordance with the principles set out in the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers;\nEnhanced quality and sustainability of research training and supervision;\nIncreased global attractiveness\, visibility and reputation of the participating organisation(s);\nStronger R&I capacity and output among participating organisations; better transfer of knowledge;\nRegular feedback of research results into teaching and education at participating organisations.\n\n\n\n\n\n\n\n\n\nDeadline model   single-stage\n\n\n\n\n\n\n\n\n\n\n\n\n\nDeadline date  13 September 2023 17:00:00 Brussels time\n\n\n\nPara ampliar esta información\, o para cualquier otra consulta\, no dudes en contactar con Elena Portero (eportero.iacs@aragon.es)\n\n\nFurther information 
URL:https://www.iacs.es/evento/msca-postdoctoral-fellowships-2023-horizon-msca-2023-pf-01/
LOCATION:San Juan Bosco\, 13\, Zaragoza\, Zaragoza\, 50009\, España
CATEGORIES:Convocatoria,Convocatoria internacional
GEO:41.64381;-0.9024
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=San Juan Bosco 13 Zaragoza Zaragoza 50009 España;X-APPLE-RADIUS=500;X-TITLE=San Juan Bosco\, 13:geo:-0.9024,41.64381
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20230414T080000
DTEND;TZID=Europe/Madrid:20230731T170000
DTSTAMP:20260426T082037
CREATED:20230414T121527Z
LAST-MODIFIED:20230414T121527Z
UID:10001761-1681459200-1690822800@www.iacs.es
SUMMARY:Preliminary announcement: Upcoming Call 2023 "Translational research on cancer epigenetics"
DESCRIPTION:The call will be published simultaneously by the funding organisations in their respective countries and on the TRANSCAN website: https://www.transcan.eu \nThe TRANSCAN-3 JTC 2023 will be implemented through a two-stage submission procedure: pre-proposals and full proposals. \nThe call is planned to be launched on May 9th 2023 with a submission deadline for pre-proposals in July 2023. It is expected that consortia invited to the full-proposal stage will be asked to submit their proposal in December 2023. \nInterested researchers and/or research teams are advised to prepare and make necessary contacts and arrangements towards preparing applications. Please see below the details of the call topics and an outline of eligibility criteria. They will be further detailed when the JTC 2023 is published. \nAims of the Call\nThe JTC 2023 of TRANSCAN-3 will focus on: \n«Translational research on cancer epigenetics « \nThe expected outcome of the call is to improve the efficacy of current detection\, diagnosis\, prognosis and treatment of cancers\, through the development of novel approaches based on a better understanding of cancer epigenetics. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original\, high-quality projects\, with significant clinical impact. \nIn the context of translational cancer research\, this call for proposals comprises two general aims. Proposals will have to cover at least one of the undermentioned aims or sub-aims. Particular attention should be given to gender balance inclusion in order to intercept sex/gender differences and to consider the role of these differences in the addressed questions. \nAim 1) The role of epigenetics in cancer initiation and progression. These studies may aim to validate novel epigenetics-based biomarkers to improve detection\, diagnosis\, prognosis of cancers or response to therapies (using recently developed innovative approaches\, multiomic approaches\, single-cell analysis\, patient-derived organoids\, patient-derived xenografts\, tumour samples collected from retrospective and/or prospective cohorts of patients or clinical trials). \n\nSpecific aim 1.1: To understand cancer initiation and progression by characterisation of the epigenetic landscape.\nSpecific aim 1.2: To define epigenetic features of cells in the tumour microenvironment that may promote tumour progression (e.g.\, immune cells\, vascular cells\, microbiota).\nSpecific aim 1.3: To study the role of epigenetic modifications as predictors of cell persistence or treatment resistance.\nSpecific aim 1.4: To validate epigenetic markers useful to improve early detection and diagnosis by exploring the correlation between epigenetics and clinical cancer manifestation.\n\nAim 2) Validation of new epigenetics-based therapeutic strategies to limit cancer progression\, prevent relapse/recurrence or increase the efficiency or reduce toxicity of existing anti-cancer therapies. \n\nSpecific aim 2.1: To validate novel therapeutic targets (novel targets should be evaluated in translational studies with regard to their impact on treatment efficacy\, safety and patient reported outcomes).\nSpecific aim 2.2: To study the potential use of epigenetic modulators to overcome resistance to anti-cancer therapies.\nSpecific aim 2.3: To develop novel epidrugs/therapeutic approaches\, through phase I and II clinical trials (investigating combinations of available treatments\, new therapeutics\, new administration schemes\, etc.) to improve safety and efficacy of treatments (objective responses; patient reported outcomes regarding morbidity and quality of life; etc.).\nSpecific aim 2.4: To develop novel theranostic approaches involving epigenetics of cancer.\n\nApplicants will have the opportunity to add an additional section for capacity building activities (with an associated separate budget\, in compliance with the rules of their respective national/regional funding organisations). These activities have to be coherent with the objectives of the research project\, and aimed to strengthening the ability of participating team(s) to perform the work detailed in the project plan as well as to improve\, in the long term\, the quality and potential of the translational research performed by the team(s). \n  \nPara ampliar esta información\, o para cualquier otra consulta\, no dudes en contactar con Elena Portero (eportero.iacs@aragon.es) \n 
URL:https://www.iacs.es/evento/preliminary-announcement-upcoming-call-2023-translational-research-on-cancer-epigenetics/
LOCATION:San Juan Bosco\, 13\, Zaragoza\, Zaragoza\, 50009\, España
CATEGORIES:Convocatoria,Convocatoria internacional
GEO:41.64381;-0.9024
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=San Juan Bosco 13 Zaragoza Zaragoza 50009 España;X-APPLE-RADIUS=500;X-TITLE=San Juan Bosco\, 13:geo:-0.9024,41.64381
END:VEVENT
END:VCALENDAR